Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 70518-3505

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 70518-3505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Lisinopril Hctz 20mg 12.5mg 70518 3505 01)

This is prescription medicine with the brand name Lisinopril/HCTZ. Each tablet contains 20mg/12.5mg of the medicine. The package has 30 tablets. The manufacturer is Sclce in Cranbury, NJ, and it has been repackaged by RemedyRepack Inc. It is important to keep this medicine out of reach of children. The package insert provides instructions for use. This medicine should be stored between 20-25°C (88-77°F), with permitted excursions of 15-30°C (59-86°F). The expiration date and LOT# are not available.*

FDA Label Image

Remedy_label (Remedy Label)

This is a prescription medicine, which is a combination of Lisinopril and HCTZ. The tablets contain 20mg Lisinopril and 12.5mg HCTZ, and the package includes 90 tablets. The lot number and expiration date are missing from the text. The medication is manufactured by Sclce in Cranbury, NJ and was repackaged by RemedyRepack Inc., Indiana, PA. The text also includes instructions for storage and keeping it out of reach of children. Directions for use are available in the package insert.*

FDA Label Image

Chemical Structure (Lisinopril)

FDA Label Image

Chemical Structure (HCTZ)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.